Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15824414rdf:typepubmed:Citationlld:pubmed
pubmed-article:15824414lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0851347lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0920321lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:15824414lifeskim:mentionsumls-concept:C1258613lld:lifeskim
pubmed-article:15824414pubmed:issue15lld:pubmed
pubmed-article:15824414pubmed:dateCreated2005-5-23lld:pubmed
pubmed-article:15824414pubmed:abstractTextPharmacologic downregulation of Bcl-2, an antiapoptotic protein overexpressed in cancer, might increase chemosensitivity in acute myeloid leukemia (AML). Herein, we investigated the feasibility of this approach in untreated elderly AML patients by administering oblimersen sodium (G3139), an 18-mer phosphorothioate antisense to Bcl-2, during induction and consolidation treatments.lld:pubmed
pubmed-article:15824414pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:languageenglld:pubmed
pubmed-article:15824414pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:citationSubsetIMlld:pubmed
pubmed-article:15824414pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15824414pubmed:statusMEDLINElld:pubmed
pubmed-article:15824414pubmed:monthMaylld:pubmed
pubmed-article:15824414pubmed:issn0732-183Xlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:ByrdJohn CJClld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:LarsonRichard...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:ChanKenneth...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:BloomfieldCla...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:StockWendyWlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:MarcucciGuido...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:GreverMichael...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:LiuShujunSlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:GreenMargaret...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:ZwiebelJames...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:DaiGuoweiGlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:KlisovicMarko...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:BlumWilliamWlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:NovickStevenSlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:MoranMollieMlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:KlisovicRebec...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:MaharryKatiKlld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:KefauverChery...lld:pubmed
pubmed-article:15824414pubmed:authorpubmed-author:SherDorie ADAlld:pubmed
pubmed-article:15824414pubmed:issnTypePrintlld:pubmed
pubmed-article:15824414pubmed:day20lld:pubmed
pubmed-article:15824414pubmed:volume23lld:pubmed
pubmed-article:15824414pubmed:ownerNLMlld:pubmed
pubmed-article:15824414pubmed:authorsCompleteYlld:pubmed
pubmed-article:15824414pubmed:pagination3404-11lld:pubmed
pubmed-article:15824414pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:meshHeadingpubmed-meshheading:15824414...lld:pubmed
pubmed-article:15824414pubmed:year2005lld:pubmed
pubmed-article:15824414pubmed:articleTitlePhase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.lld:pubmed
pubmed-article:15824414pubmed:affiliationDivision of Hematology-Oncology, The Comprehensive Cancer Center, The Ohio State University, 433A Starling-Loving Hall, 320 West 10th Ave, Columbus, OH 43210, USA. marcucci-1@medctr.osu.edulld:pubmed
pubmed-article:15824414pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15824414pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15824414pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15824414pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15824414pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15824414pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
pubmed-article:15824414pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15824414lld:pubmed